Cytovale

Microfluidic-based biomarkers for the early detection of sepsis

placeSan Francisco, California, United States calendar_todayFounded 2013 groups58 employees language cytovale.com

Registered entities

Innovation

7 patent families (5 granted) — focus: Operations & transport, Physics & computing; filing pace accelerating. Cited 1,096 times.

YearFilings
20172
20191
20211
20221
20234
20244
20254
20261

Social engagement

Social engagement: 15.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

20 investors on record; lead investors include Sands Capital, Breakout Ventures, Blackhorn Ventures, Norwest.

Investor typeCountShare
Venture capital1050%
Private equity15%
Bank & private debt15%
Other / undisclosed840%

Hiring activity

Hires periodically

7 roles tracked across 5 of the last 12 months

10 Apr 2026 · Director, Medical Science Liaisons · South San Francisco

10 Mar 2026 · IT Manager · South San Francisco

26 Feb 2026 · Senior Clinical Data Research Engineer · South San Francisco

25 Feb 2026 · Verification Tester - 7 Month Contract role · South San Francisco

24 Dec 2025 · Contract Manufacturing Lab Engineer · San Francisco

Based on job postings tracked across public sources.

Recent activity

24 Jun 2026
Event
How a Novel Sepsis Diagnostic Enables Life-Saving Decisions: New Real-World Evidence
18 Jun 2026
Event
How a Novel Sepsis Diagnostic Enables Life-Saving Decisions: New Real-World Evidence
10 Jun 2026
Event
United for Sepsis Symposium
Coming soon